Dr Stephen McDonough, UK medical director at GSK, looks at the changing relationship between industry and health professionals and how the company is adapting to society’s growing demand for greater transparency
The eyes of our industry are looking ahead to new rules that will come into effect this year which will influence how healthcare companies work with the medical professions. These new rules will affect every pharmaceutical company that is a member of its national business association.